Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.
about
A nonrandomized trial of vitamin D supplementation for Barrett's esophagus.Vitamin D in esophageal cancer: Is there a role for chemoprevention?The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival.ETS1 is associated with cisplatin resistance through IKKα/NF-κB pathway in cell line MDA-MB-231.
P2860
Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Vitamin D Receptor Polymorphis ...... sophageal Adenocarcinoma Risk.
@ast
Vitamin D Receptor Polymorphis ...... sophageal Adenocarcinoma Risk.
@en
type
label
Vitamin D Receptor Polymorphis ...... sophageal Adenocarcinoma Risk.
@ast
Vitamin D Receptor Polymorphis ...... sophageal Adenocarcinoma Risk.
@en
prefLabel
Vitamin D Receptor Polymorphis ...... sophageal Adenocarcinoma Risk.
@ast
Vitamin D Receptor Polymorphis ...... sophageal Adenocarcinoma Risk.
@en
P2093
P2860
P50
P1433
P1476
Vitamin D Receptor Polymorphis ...... Esophageal Adenocarcinoma Risk
@en
P2093
André G Uitterlinden
Anouk Van De Winkel
Farzin Pourfarzad
Hugo W Tilanus
Kausilia K Krishnadath
Pascal P Arp
P2860
P2888
P304
P356
10.2119/MOLMED.2012.00336
P407
P50
P577
2015-04-21T00:00:00Z
P5875
P6179
1068965584